Clinical and pathological analysis of acute rejection following orthotopic liver transplantation

Chinese Medical Journal

Volumn 122, Issue 12, 2009, Pages 1400-1403

  Ma, Yi ^a   Wang, Guo Dong ^a   He, Xiao Shun ^a   Li, Jun Liang ^a   Zhu, Xiao Feng ^a   Hu, Rui De ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Acute rejection; Liver biopsy; Liver transplantation; Treatment

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; DRUG PULSE THERAPY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; RETRANSPLANTATION; SCHOOL CHILD; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; YOUNG ADULT;

EID: 68249153229     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.12.008     Document Type: Article

References (24)

1. Manzarbeitia C, Rustgi VK, Jonsson J, Oyloe VK. Absolute peripheral blood eosinophilia. An early marker for rejection in clinical liver transplantation. Transplantation 1995; 59: 1358-1360.
2. Pan TL, Chen CL, Lin CL, Lai CY, Tseng HP, Chiang KC, et al. Ceruloplasmin, a novel candidate as a diagnostic marker for liver function after liver transplantation. Transplant Proc 2000; 32: 2198.
3. Ma Y, Zhu XF, He XS. Surgical technique of rapid procurement and back table procedures of liver graft. Chin J Pract Surg (Chin) 2006; 26:128-130.
4. Wu YM, Voigt M, Rayhill S, Katz D, Chenhsu RY, Schmidt W, et al. Suprahepatic venacavaplasty (cavaplasty) with retrohepatic cava extension in liver transplantation: experience with first 115 cases. Transplantation 2001; 72: 1389-1394.
5. International Panel. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658-663.
6. Drachenberg CB, Odorico J, Demetris AJ, Arend L, Bajema IM, Bruijn JA, et al. Banff schema for grading pancreas allograft rejection: working proposal by a multi disciplinary international consensus panel. Am J Transplant 2008; 8: 1237-1249.
7. Hubscher SG. Histological findings in liver allograft rejection-new insights into the pathogenesis of hepatocellular damage in liver allografts. Histopathology 1991; 18: 377-383.
8. Hubscher SG. Diagnosis and grading of liver allograft rejection: a European perspective. Transplant Proc 1996; 28: 504-507.
9. Banff Working Group, Demetris AJ, Adeyi O, Bellamy CO, Clouston A, Charlotte F, et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44: 489-501.
10. Górnicka B, Ziarkiewicz Wróblewska B, Bogdańska M, Ołdakowska-Jedynak U, Wroblewski T, et al. Pathomorphological features of acute rejection in patients after orthotopic liver transplantation: own experience. Transplant Proc 2006; 38: 221-225.
11. Lupo L, Panzera P, Tandoi F, Carbotta G, Giannelli G, Santantonio T, et al. Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial. Transplantation 2008; 86: 925-931.
12. Portmann B. Liver allograft pathology and biopsy interpretation. Verh Dtsch Ges Pathol 2004; 88: 29-38.
13. Matinlauri IH, Nurminen MM, Isoniemi HM. Changes in liver graft rejections over time. Transplant Proc 2006; 38: 2663-2666.
14. Takahashi H, Kato T, Delacruz V, Nishida S, Selvaggi G, Weppler D, et al. Analysis of acute and chronic rejection in multiple organ allografts from retransplantation and autopsy cases of multivisceral transplantation. Transplantation 2008; 85: 1610-1616.
15. Bueno J, Medina A, Ortega J, Escartin A, Bello M, Bilbao I, et al. Liver transplantation in childhood with more than 10 years of follow up: analysis of a single center experience. Transplant Proc 2007; 39: 2288-2289.
16. Karakayali H, Ekici Y, Ozcay F, Bilezikci B, Arslan G, Haberal M. Pediatric liver transplantation for acute liver failure. Transplant Proc 2007; 39: 1157-1160.
17. Neil DA, Hubscher SG. Are paerchymal changes in early posttransplant biopsies related to preservation injury or rejection. Transplantation 2001; 71: 1566-1572.
18. Pfitzmann R, Nüssler NC, Hippler-Benscheidt M, Neuhaus R, Neuhaus P. Long term results after liver transplantation. Transpl Int 2008; 21: 234-246.
19. Jain A, Reyes J, Kashyap R, Rohal S, Abu Elmagd K, Starzl T. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long term follow up of the first 1000 patients. Ann Surg 1999; 230: 441-448.
20. Jacob DA, Neumann UP, Bahra M, Klupp J, Puhl G, Neuhaus R, et al. Long term follow up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Clin Transplant 2006; 20: 211-220.
21. Ma Y, He XS, Zhu XF, Wang GD. The reason and treatment of hyperbilirubinemia after orthotopic liver transplantation. Chin J Hepatology (Chin) 2008; 16: 117-120.
22. Ma Y, Wang GD, He XS, Li JL. Liver retransplantation: a single centre experience. Chin Med J 2008; 121: 1987-1991.
23. Chen GH, Fu BS, Yang Y, Cai CJ, Lu MQ, Li H, et al. Early liver retransplantation versus late liver retransplantation: analysis of a single-center experience. Chin Med J 2008; 121: 1992-1996.
24. Alamo JM, Gómez MA, Pareja F, Martínez A, López F, Romero E, et al. Morbidity and mortality in liver retransplantation. Transplant Proc 2006; 38: 2475-2477.